These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 11161961)

  • 21. Effect of chronic renal failure and prednisolone on the growth hormone-insulin-like growth factor axis.
    Kapila P; Jones J; Rees L
    Pediatr Nephrol; 2001 Dec; 16(12):1099-104. PubMed ID: 11793109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety of recombinant human growth hormone in treating children with growth hormone deficiency and idiopathic short stature.
    Chang S; Hui P
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Apr; 33(2):123-6. PubMed ID: 21529437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adverse events with rhGH treatment of patients with chronic renal insufficiency and end-stage renal disease.
    Fine RN; Ho M; Tejani A; Blethen S
    J Pediatr; 2003 May; 142(5):539-45. PubMed ID: 12756387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W; Briody J; Moore B; Lu PW; Cowell CT
    Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth hormone safety update from the National Cooperative Growth Study.
    Maneatis T; Baptista J; Connelly K; Blethen S
    J Pediatr Endocrinol Metab; 2000 Sep; 13 Suppl 2():1035-44. PubMed ID: 11086659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety of recombinant deoxyribonucleic acid-derived growth hormone: The National Cooperative Growth Study experience.
    Blethen SL; Allen DB; Graves D; August G; Moshang T; Rosenfeld R
    J Clin Endocrinol Metab; 1996 May; 81(5):1704-10. PubMed ID: 8626820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complications of growth hormone therapy in children.
    Blethen SL
    Curr Opin Pediatr; 1995 Aug; 7(4):466-71. PubMed ID: 7581653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [How safe is the recombinant human growth hormone?].
    Calzada-León R
    Rev Med Inst Mex Seguro Soc; 2017; 55(3):341-352. PubMed ID: 28440988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Headache, idiopathic intracranial hypertension and slipped capital femoral epiphysis during growth hormone treatment: a safety update from the KIGS database.
    Darendeliler F; Karagiannis G; Wilton P
    Horm Res; 2007; 68 Suppl 5():41-7. PubMed ID: 18174706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Visual loss without headache in children with pseudotumor cerebri and growth hormone treatment.
    Besch D; Makowski C; Steinborn MM; Bonfig W; Sadowski B
    Neuropediatrics; 2013 Aug; 44(4):203-7. PubMed ID: 23275258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term safety of recombinant human growth hormone in children.
    Bell J; Parker KL; Swinford RD; Hoffman AR; Maneatis T; Lippe B
    J Clin Endocrinol Metab; 2010 Jan; 95(1):167-77. PubMed ID: 19906787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and efficacy of growth hormone therapy in childhood.
    Bowlby DA; Rapaport R
    Pediatr Endocrinol Rev; 2004 Nov; 2 Suppl 1():68-77. PubMed ID: 16456485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association Between Recombinant Growth Hormone Therapy and All-Cause Mortality and Cancer Risk in Childhood: Systematic Review and Meta-Analysis.
    He M; Deng X; Wang X; Wan Y; Huang J; Zhang Z; Niu W
    Front Pediatr; 2022; 10():866295. PubMed ID: 35529328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short and Long-Term Effects of Growth Hormone in Children and Adolescents With GH Deficiency.
    Ranke MB
    Front Endocrinol (Lausanne); 2021; 12():720419. PubMed ID: 34539573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of anterior-posterior spinal curvatures in children suffering from hypopituitarism.
    Kobylińska M; Malak R; Majewska K; Kędzia A; Samborski W
    BMC Endocr Disord; 2019 Dec; 19(1):137. PubMed ID: 31829163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety Outcomes During Pediatric GH Therapy: Final Results From the Prospective GeNeSIS Observational Program.
    Child CJ; Zimmermann AG; Chrousos GP; Cummings E; Deal CL; Hasegawa T; Jia N; Lawrence S; Linglart A; Loche S; Maghnie M; Pérez Sánchez J; Polak M; Predieri B; Richter-Unruh A; Rosenfeld RG; Yeste D; Yorifuji T; Blum WF
    J Clin Endocrinol Metab; 2019 Feb; 104(2):379-389. PubMed ID: 30219920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence of diabetes mellitus and neoplasia in Japanese short-statured children treated with growth hormone in the Genetics and Neuroendocrinology of Short Stature International Study (GeNeSIS).
    Yokoya S; Hasegawa T; Ozono K; Tanaka H; Kanzaki S; Tanaka T; Chihara K; Jia N; Child CJ; Ihara K; Funai J; Iwamoto N; Seino Y
    Clin Pediatr Endocrinol; 2017; 26(4):229-241. PubMed ID: 29026272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stories of experiences of care for growth hormone deficiency: the CRESCERE project.
    Marini MG; Chesi P; Mazzanti L; Guazzarotti L; Toni TD; Salerno MC; Officioso A; Parpagnoli M; Angeletti C; Faienza MF; Iezzi ML; Aversa T; Sacchetti C
    Future Sci OA; 2016 Mar; 2(1):FSO82. PubMed ID: 28031934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of financial support on treatment of adolescents with growth hormone deficiency: a retrospective study in Japan.
    Maeda E; Higashi T; Hasegawa T; Yokoya S; Mochizuki T; Ishii T; Ito J; Kanzaki S; Shimatsu A; Takano K; Tajima T; Tanaka H; Tanahashi Y; Teramoto A; Nagai T; Hanew K; Horikawa R; Yorifuji T; Wada N; Tanaka T
    BMC Health Serv Res; 2016 Oct; 16(1):602. PubMed ID: 27769307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of growth hormone treatment in children with short stature: the Italian cohort of the GeNeSIS clinical study.
    Cappa M; Iughetti L; Loche S; Maghnie M; Vottero A;
    J Endocrinol Invest; 2016 Jun; 39(6):667-77. PubMed ID: 27223400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.